ion channel drug discovery · 2020. 7. 16. · schizophrenia down syndrome fragile x syndrome...

The University of Sydney Page 1

Ion Channel Drug Discovery

Presented byProfessor Mary Collins ChebibBrain and Mind CentreSchool of PharmacyThe University of Sydney

The University of Sydney Page 2

Ion Channel Drug Discovery Team

• A/Prof Thomas Balle

The University of Sydney Page 3

Cys-loop receptor family

• Cys-loop receptors consist of GABAA, nicotinic, 5-HT3 and glycine receptors

anxiety, sleep disorders, epilepsy BDZ sensitive receptors

The University of Sydney Page 4

GABAA receptor subtypes mediate distinct physiological effects

AD, Down’s syndrome, stroke recovery

The development of subtype selective agents is necessary and challenging but will reduce unwanted effects

OtherTargets

Motor deficits

?

?

?

Undesired activity

”Acceptable” (anxiolysis)?

The University of Sydney Page 5

Evaluation of agents using behavioural and neurochemical methods

Other behavioural assessments including anxiety, memory and learning

Neurochemical assessments including binding, autoradiography and immunohistochemistry

In vitro functional assessment of agents using 2-electrode voltage clamp methods

The University of Sydney Page 6

What we would like from DDI

– DDI PhD scholarships– High-through put screening capabilities– Access/collaborations using slice electrophysiology– Access/collaborations in other behavioural models– Access to ADME